Keyphrases
Polycystic Ovary Syndrome
86%
Systematic Meta-analysis
75%
Meta-analysis
75%
Assisted Reproductive Technology
66%
Postpartum Contraception
50%
Hyperprolactinemia
50%
Confidence Interval
47%
Pregnancy Rate
45%
Prolactin
37%
Insulin
35%
Hirsutism
33%
Randomized Trial
33%
Insulin Sensitizers
33%
Follicular Phase
31%
Insulin Resistance
31%
Unprotected Sex
30%
Fertility Treatment
29%
Live Birth Rate
29%
Overweight or Obesity
29%
Infertile Women
28%
Gestational Diabetes
28%
Hyperinsulinism
27%
Levonorgestrel
26%
Ethinylestradiol
26%
Metoclopramide
25%
Macroprolactinemia
25%
Follicular Phase Stimulation
25%
Weight Decrease
25%
Self-scoring
25%
Letrozole
25%
Female Fertility Preservation
25%
Gonadotropin-releasing Hormone Antagonist
25%
Random Start
25%
Pelvic Floor muscle Training
25%
Metabolic Syndrome
25%
Serum Androgens
25%
Obese Women
25%
Weight Loss
25%
Physical Activity Intervention
25%
Individual Participant Data Meta-analysis
25%
Lifestyle Intervention
25%
Birth Outcomes
25%
Observational Comparative Studies
25%
Intervention Group
25%
Effectiveness Evaluation
25%
Treatment Protocol
25%
Response Profiles
25%
Pregnancy Outcome
25%
Human Chorionic Gonadotropin
25%
Pituitary Response
25%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Polycystic Ovary Syndrome
77%
Assisted Reproduction
54%
Pregnancy Rate
47%
Assisted Reproductive Technology
39%
Androgen
37%
Insulin Resistance
36%
Hirsutism
33%
Follicular Phase
31%
Hyperinsulinism
30%
Insulin Sensitizing Agent
29%
Clinician
29%
Obesity
29%
Birth Rate
29%
Gestational Diabetes
28%
Emergency Contraception
25%
Prevalence
25%
Gonadorelin Antagonist
25%
Physical Activity
25%
Fertility Preservation
25%
Body Weight Loss
25%
Chorionic Gonadotropin
25%
Glucose Metabolism
25%
Urine Incontinence
25%
Kegel Exercise
25%
Letrozole
25%
Levonorgestrel
25%
Microscopy
25%
Unwanted Pregnancy
25%
Vagina Smear
25%
Ethinylestradiol
25%
Randomized Controlled Trial
25%
Birth Outcomes
25%
Lifestyle Intervention
25%
Oocyte
22%
Spontaneous Abortion
20%
Follitropin
19%
Reproductive Medicine
17%
Menstrual Cycle
15%
Glycon
14%
Quantitative Insulin Sensitivity Check Index
13%
Diethylstilbestrol
12%
Controlled Ovarian Hyperstimulation
12%
Randomized Clinical Trial
11%
Impaired Glucose Tolerance
9%
Testosterone
9%
Glucose Tolerance
9%
Childbirth
8%
Hyperandrogenism
8%